Holders — by stockHoldings — by fund
ENAVATE SCIENCES GP, LLC
Everything this manager disclosed owning in US-listed stocks — its complete Form 13F portfolio · as of 2026-06-30 · filed with the SEC up to 45 days after quarter end · CIK 0001953107
$345.4M
disclosed book value
7
positions
31.6%
largest position share
Positions, as of 2026-06-30
top 7 of 7 · 13F covers long US-listed positions only — cash, bonds, private and foreign stakes are not disclosed · PUT/CALL tags = options positions (share-equivalents), not shares held
| # | Issuer | Shares | Value | % of book |
|---|---|---|---|---|
| 1 | SIONSIONNA THERAPEUTICS INC | 2.5M | $109.0M | 31.6% |
| 2 | ZBIOZENAS BIOPHARMA INC | 3.9M | $99.5M | 28.8% |
| 3 | IMNMIMMUNOME INC | 3.6M | $76.6M | 22.2% |
| 4 | BBOTBRIDGEBIO ONCOLOGY THERAPEUT | 2.6M | $20.0M | 5.8% |
| 5 | CMPXCOMPASS THERAPEUTICS INC | 7.8M | $17.1M | 4.9% |
| 6 | UPBUPSTREAM BIO INC | 2.5M | $17.0M | 4.9% |
| 7 | CAMPCAMP4 THERAPEUTICS CORP | 1.4M | $6.2M | 1.8% |
Source: SEC Form 13F-HR, reporting period 2026-06-30. Values are the manager's filed June-30-style quarter-end marks, not live prices. Research, not investment advice.